MedTrace Logo

Online Versions of Single Session Virtual Reality (VR) Therapy and EMDR Flash Therapy on the Treatment of Flying Fear

NCT06758635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 89

Last updated 2025-01-06

No results posted yet for this study

Summary

The purpose of this experimental study is to explore effectiveness of Cognitive Behavioural Therapy based Virtual Reality Therapy and Eye Movement Desensitization and Reprocessing Therapy based Flash Technique compared to psychoeducation only group through developing one session online protocols. Follow up will be performed one month after the intervention.

Accordingly, 89 people who applied voluntarily were divided into three groups randomly:

1. psychoeducation and Virtual reality therapy
2. Flash technique
3. psychoeducation-only.

All participants were given a set of scales consisting:

1. The Clinical Global Impressions Scale
2. FAM (Flight Anxiety Modality Questionnaire),
3. FAS (Flight Anxiety Situations Questionnaire), and
4. Visual Analogue Flight Anxiety Scale (VAFAS), to assess the level of fear of flying before and one month after the treatment.

This work was supported by the Research Fund of Ibn Haldun University. Project Name: Online Single Session Virtual Reality Therapy Programme for Fear of Flying. Project Number: 2238.

Conditions

  • Fear of Flying

Interventions

BEHAVIORAL

VRET-O Group

Arm Description: the participants of this group will get 3 hours lasting online single session VR therapy

BEHAVIORAL

Flash-O Group

Arm Description: the participants of this group will get 3 hours lasting online single session EMDR Flash therapy

BEHAVIORAL

PYSCHOEDU-O Group

Arm Description: the participants of this group will get 1 hour lasting online psychotherapy

Sponsors & Collaborators

  • Ibn Haldun University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2024-08-15
Completion
2024-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06758635 on ClinicalTrials.gov